VKH
EDIT icon

Virtu KCG Holdings’s Editas Medicine EDIT Stock Holding History

Virtu KCG Holdings’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$486K Buy
+28,970
New +$522K 0.01% 1171

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Virtu KCG Holdings's EDIT Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Editas Medicine (EDIT) in Q2 2017: 28,970 shares worth $486K. The stake represents 0.01% of the portfolio and ranks #1171 among its holdings.

110 funds tracked by Wall St. Rank hold EDIT as of Q2 2017.

  • Virtu KCG Holdings held 28,970 shares of Editas Medicine worth $486K as of Q2 2017.
  • Editas Medicine was a new Virtu KCG Holdings position in Q2 2017.
  • Editas Medicine made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1171 holding.
  • 110 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.